Triad Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
VCM
Triad Wealth Partners's TMO Position: Q1 2026 in Review
Triad Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, selling an estimated $29.3K and leaving 436 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #458.
Triad Wealth Partners first reported a position in TMO in Q2 2024 and has held it in 3 quarters since. The position peaked at $284K in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Triad Wealth Partners held 436 shares of Thermo Fisher Scientific worth $214K as of Q1 2026.
- Triad Wealth Partners sold 54 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.3K.
- Thermo Fisher Scientific made up 0.02% of Triad Wealth Partners's portfolio in Q1 2026, its #458 holding.
- Triad Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 3 quarters since.
- Triad Wealth Partners's Thermo Fisher Scientific position peaked at $284K in Q4 2025.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.